News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn Engineering Researchers Develop New Technology that Transforms Reflective Displays
The invention consists of an array of individually addressable microscale optical resonators and arrangements of optical components which allow a beam of light to circulate more efficiently.
PCI and Philadelphia Are Highlighted as Innovation Hubsat SXSW
The conference allowed PCI team members to meet a global network of investors and tech innovators.
2023 President’s Prize Winners: Where They Are Now?
The 2023 President’s Innovation Prize (PIP) and President’s Engagement Prize (PEP) winners have each made significant strides over the course of the past year.
LNP Research from the Mitchell Lab is Highlighted in the Philadelphia Inquirer
Mike Mitchell, PhD, was interviewed recently by the Philadelphia Inquirer about his cutting-edge research in lipid nanoparticles (LNPs), which are crucial for delivering mRNA into the body's cells.
Penn Vet Announces mRNA Research Initiative for Veterinary Vaccine Science
The University of Pennsylvania School of Veterinary Medicine (Penn Vet) has launched an mRNA Research Initiative to advance the development of veterinary mRNA-based vaccines and therapies.
Penn’s CAR-T Treatment Shrank Brain Tumors in Patients in Clinical Trial
In a new early-stage clinical trial, a Penn-invented CAR-T treatment shrank brain tumors in seven patients with glioblastoma.
PA as an Innovation Leader: Challenges and Solutions in the face of a Growing Industry
Pennsylvania legislators are working on new ways to retain young residents who too often leave the region for opportunities after receiving their education within the state.
New Proposed Federal Guidelines Could Threaten Innovation
Recently proposed guidance could expand "march-in rights" under the Bayh-Dole Act, significantly impacting the development of products from federally funded research.
Novel Therapeutics Forum Brings Together Investors and Innovators at Penn
PCI and Penn Medicine partnered with Citizens JMP for the inaugural ‘Novel Therapeutics Forum’ at Penn.
ToxiSense Develops Plant-Based Alternativeto Horseshoe Crab Blood
ToxiSense is developing a plant-based alternative to test for bacterial toxins in vaccines and medical devices, which could eliminate the current need for bloodletting of horseshoe crabs.